Article Versions Notes

Qian K, Cai Z, Liu R, Yang W, Liu J, Wu M, Zhu M, Wang L, Gan H, Yang Z, et al. A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR⁺ Breast Cancer. Biomedicines. 2026; 14(3):592. https://doi.org/10.3390/biomedicines14030592

Qian, Keyang, Zijie Cai, Ruiquan Liu, Wang Yang, Jiayi Liu, Mengzi Wu, Mengdi Zhu, Linghan Wang, Huipei Gan, Zhuangqiu Yang, and et al. 2026. "A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR⁺ Breast Cancer" Biomedicines 14, no. 3: 592. https://doi.org/10.3390/biomedicines14030592

Qian, K., Cai, Z., Liu, R., Yang, W., Liu, J., Wu, M., Zhu, M., Wang, L., Gan, H., Yang, Z., Jiang, X., Shen, C., Mao, Y., & Liu, Q. (2026). A Tumor-Agnostic, Topology-Informed Scoring Framework for Drug Repurposing: Application to CDK4/6 Inhibitor Resistance in HR⁺ Breast Cancer. Biomedicines, 14(3), 592. https://doi.org/10.3390/biomedicines14030592